A comparison of dermatologists', surgeons' and general practitioners' surgical management of cutaneous melanoma.
2/5 보강
🔎 핵심 키워드
cutaneous melanoma
melanoma
primary cutaneous malignant melanoma
malignant melanoma
tumour
lentigo maligna melanomas
nodular melanomas
cutaneous malignant melanoma
전체 NER ↓
PICO 자동 추출 (휴리스틱, conf 3/4)
유사 논문P · Population 대상 환자/모집단
1536 patients, 663 (43%) were treated initially by a dermatologist, 486 (32%) by a general surgeon, 257 (17%) by a plastic surgeon and 130 (8%) by a GP.
I · Intervention 중재 / 시술
dermatologists, general surgeons, plastic surgeons and general practitioners (GPs)
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
[CONCLUSIONS] This study showed that dermatologists manage an increasing majority of melanoma patients and that there were significant differences in the surgical treatment of melanoma between dermatologists and surgeons. Survival was significantly better in the dermatology-treated group, suggesting that dermatologists should have a central role in melanoma management.
【연구 목적】 피부과 전문의, 일반외과 의사, 성형외과 의사, 일반의(GP)가 치료한 원발성 피부 흑색종 환자의 임상병리학적 특징과 수술적 관리의 차이를 규명하고, 치료 전문직군에 따른 생존율 차이가 존재하는지 확인하는 것이 본 연구의 핵심 목표이다.
APA
McKenna DB, Marioni JC, et al. (2004). A comparison of dermatologists', surgeons' and general practitioners' surgical management of cutaneous melanoma.. The British journal of dermatology, 151(3), 636-44. https://doi.org/10.1111/j.1365-2133.2004.06065.x
MLA
McKenna DB, et al.. "A comparison of dermatologists', surgeons' and general practitioners' surgical management of cutaneous melanoma.." The British journal of dermatology, vol. 151, no. 3, 2004, pp. 636-44.
PMID
15377351 ↗
Abstract 한글 요약
[BACKGROUND] Current guidelines for the surgical management of melanoma aim to bring a combined consensus approach to the surgery of melanoma. Whether different outcomes for melanoma are related to the specialist who treats the patient is unknown.
[OBJECTIVES] To examine the clinicopathological features and surgical management of patients with primary cutaneous malignant melanoma treated by dermatologists, general surgeons, plastic surgeons and general practitioners (GPs). We also examined if the category of specialist had an effect on the survival outcome for the patient.
[METHODS] A retrospective, observational study of patients registered on a specialist database that records the clinicopathological features, surgical treatment and follow-up information of patients with malignant melanoma in Scotland. The patients had invasive primary cutaneous malignant melanoma without evidence of metastasis at the time of surgery, diagnosed between 1979 and 1997, with follow-up to the end of December 1999. Clinicopathological characteristics and surgical treatment of patients were compared for the four groups of specialist, as were overall survival (OS), disease-free survival (DFS) and recurrence-free interval (RF).
[RESULTS] Of 1536 patients, 663 (43%) were treated initially by a dermatologist, 486 (32%) by a general surgeon, 257 (17%) by a plastic surgeon and 130 (8%) by a GP. The proportion of patients managed by dermatologists rose over the lifetime of the study. Compared with the other specialists, the patients treated by general and plastic surgeons were older; a higher proportion of female patients was managed by dermatologists; median tumour thickness, lesion diameter and frequency of ulceration were all greater in the general surgeon-treated group; plastic surgeons treated a higher proportion of lentigo maligna melanomas; and general surgeons and GPs saw a higher proportion of nodular melanomas. Over 90% of patients managed by a dermatologist or GP underwent wider local excision following initial excision, compared with 43% and 25%, respectively, in the general and plastic surgery groups. General surgeons used wider excision margins than the other specialists. OS, DFS and RF were significantly better in the dermatology group compared with the general and plastic surgery groups.
[CONCLUSIONS] This study showed that dermatologists manage an increasing majority of melanoma patients and that there were significant differences in the surgical treatment of melanoma between dermatologists and surgeons. Survival was significantly better in the dermatology-treated group, suggesting that dermatologists should have a central role in melanoma management.
[OBJECTIVES] To examine the clinicopathological features and surgical management of patients with primary cutaneous malignant melanoma treated by dermatologists, general surgeons, plastic surgeons and general practitioners (GPs). We also examined if the category of specialist had an effect on the survival outcome for the patient.
[METHODS] A retrospective, observational study of patients registered on a specialist database that records the clinicopathological features, surgical treatment and follow-up information of patients with malignant melanoma in Scotland. The patients had invasive primary cutaneous malignant melanoma without evidence of metastasis at the time of surgery, diagnosed between 1979 and 1997, with follow-up to the end of December 1999. Clinicopathological characteristics and surgical treatment of patients were compared for the four groups of specialist, as were overall survival (OS), disease-free survival (DFS) and recurrence-free interval (RF).
[RESULTS] Of 1536 patients, 663 (43%) were treated initially by a dermatologist, 486 (32%) by a general surgeon, 257 (17%) by a plastic surgeon and 130 (8%) by a GP. The proportion of patients managed by dermatologists rose over the lifetime of the study. Compared with the other specialists, the patients treated by general and plastic surgeons were older; a higher proportion of female patients was managed by dermatologists; median tumour thickness, lesion diameter and frequency of ulceration were all greater in the general surgeon-treated group; plastic surgeons treated a higher proportion of lentigo maligna melanomas; and general surgeons and GPs saw a higher proportion of nodular melanomas. Over 90% of patients managed by a dermatologist or GP underwent wider local excision following initial excision, compared with 43% and 25%, respectively, in the general and plastic surgery groups. General surgeons used wider excision margins than the other specialists. OS, DFS and RF were significantly better in the dermatology group compared with the general and plastic surgery groups.
[CONCLUSIONS] This study showed that dermatologists manage an increasing majority of melanoma patients and that there were significant differences in the surgical treatment of melanoma between dermatologists and surgeons. Survival was significantly better in the dermatology-treated group, suggesting that dermatologists should have a central role in melanoma management.
【연구 목적】
피부과 전문의, 일반외과 의사, 성형외과 의사, 일반의(GP)가 치료한 원발성 피부 흑색종 환자의 임상병리학적 특징과 수술적 관리의 차이를 규명하고, 치료 전문직군에 따른 생존율 차이가 존재하는지 확인하는 것이 본 연구의 핵심 목표이다.
【방법】
1979년부터 1997년 사이에 진단된 전이 증거 없는 침습성 원발성 피부 흑색종 환자 1,536명을 대상으로 스코틀랜드의 전문 데이터베이스를 이용한 후향적 관찰 연구를 수행하였다. 각 전문직군(피부과 43%, 일반외과 32%, 성형외과 17%, 일반의 8%)별 환자의 임상병리학적 특성, 수술적 치료 방식(광범위 국소 절제술 시행률 및 절제 여백), 그리고 전체 생존율(OS), 무병 생존율(DFS), 재발-free 간격(RF)을 비교 분석하였다.
【주요 결과】
피부과 전문의가 치료한 환자군은 일반외과 및 성형외과 전문의가 치료한 환자군에 비해 전체 생존율(OS), 무병 생존율(DFS), 재발-free 간격(RF)이 통계적으로 유의하게 우수하였다. 또한 피부과와 일반의가 치료한 환자군의 90% 이상이 초기 절제 후 광범위 국소 절제술을 받았으나, 일반외과와 성형외과 그룹에서는 각각 43%와 25%에 그쳤다. 일반외과 의사들은 다른 전문직군에 비해 더 넓은 절제 여백을 사용하였으며, 성형외과 의사는 레티고 말리그나 흑색종, 일반외과와 일반의는 결절성 흑색종을 더 많이 치료하는 경향이 있었다.
【임상적 시사점 (성형외과 의사 관점)】
본 연구는 성형외과 의사가 흑색종 수술을 수행할 때 광범위 국소 절제술(wider local excision)의 시행률이 피부과에 비해 현저히 낮았음을 시사하며, 이는 재발 방지를 위한 수술적 접근의 표준화 필요성을 강조한다. 성형외과 의사는 레티고 말리나 흑색종 등 특정 아형의 흑색종을 주로 다루는 경향이 있으므로, 이러한 종양의 생물학적 특성에 기반한 정밀한 절제 여백 결정이 필수적이다. 생존율 결과에서 성형외과 그룹이 피부과 그룹보다 불리한 결과를 보였으므로, 수술 전 종양의 두께와 궤양 유무 등 임상병리학적 위험 인자를 철저히 평가하여 수술 범위를 결정해야 한다. 성형외과 의사는 단순한 종양 절제를 넘어 재건적 측면에서의 접근이 가능하므로, 광범위 절제 후 발생할 수 있는 조직 결손에 대한 사전 계획과 재건술의 조화가 전신 생존율 개선에 간접적으로 기여할 수 있음을 인지해야 한다. 특히 일반외과 의사들이 더 넓은 절제 여백을 사용했다는 점은 성형외과 의사들도 종양의 국소 재발을 최소화하기 위해 기존 관행보다 더 공격적인 절제 범위를 고려할 필요가 있음을 의미한다. 마지막으로 흑색종 관리에서 다학제 협진의 중요성을 시사하므로, 피부과 전문의와의 긴밀한 소통을 통해 수술적 관리의 격차를 줄이고 환자 예후를 최적화해야 한다.
추출된 의학 개체 (NER)
전체 NER 표 보기
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 질환 | cutaneous melanoma
|
C0025202
melanoma
|
scispacy | 1 | |
| 질환 | melanoma
|
C0025202
melanoma
|
scispacy | 1 | |
| 질환 | primary cutaneous malignant melanoma
|
C0151779
Cutaneous Melanoma
|
scispacy | 1 | |
| 질환 | malignant melanoma
|
C0025202
melanoma
|
scispacy | 1 | |
| 질환 | tumour
|
C0027651
Neoplasms
|
scispacy | 1 | |
| 질환 | lentigo maligna melanomas
|
C2739810
Lentigo maligna melanoma
|
scispacy | 1 | |
| 질환 | nodular melanomas
|
C0334424
Nodular melanoma
|
scispacy | 1 | |
| 질환 | cutaneous malignant melanoma
|
scispacy | 1 | ||
| 질환 | melanoma patients
|
scispacy | 1 |
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.
- Early local immune activation following intra-operative radiotherapy in human breast tissue.
- Impact of Comorbidities on Clinical Outcomes and Quality of Life of Patients With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative (HR+/HER2-) Advanced Breast Cancer Treated With Palbociclib in the POLARIS Study.
- Whole-body MRI for staging and follow-up of primary musculoskeletal tumours: a systematic review.